Ginkgo Bioworks Holdings, Inc. stock is up 5.47% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 9 PUTs, 1 CALL. 0% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
02 Nov 19:40 | 19 Jan, 2024 | 3.00 | 7574 | ||
02 Nov 19:40 | 19 Jan, 2024 | 3.00 | 7574 | ||
02 Nov 19:40 | 19 Jan, 2024 | 3.00 | 7574 | ||
02 Nov 19:40 | 19 Jan, 2024 | 3.00 | 7574 | ||
02 Nov 19:57 | 19 Jan, 2024 | 3.00 | 7574 | ||
08 Nov 20:46 | 17 Jan, 2025 | 3.00 | 2082 | ||
09 Nov 15:20 | 15 Dec, 2023 | 1.50 | 2873 | ||
27 Nov 18:30 | 17 Jan, 2025 | 1.50 | 4602 | ||
27 Nov 18:31 | 17 Jan, 2025 | 1.50 | 4602 | ||
30 Nov 19:56 | 15 Mar, 2024 | 1.00 | 664 |
Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals.